GlassScriptPhysician profile
Paul I Cook
NPI 1871663476
$11,714.29
in general payments reported to CMS, 2019-2025
47 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $566 · 2021: $1,581 · 2022: $1,831 · 2023: $6,255 · 2024: $490 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,016 · Food and Beverage: $1,715 · Travel and Lodging: $292 · Entertainment: $13.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,016.00 |
| Food and Beverage | $1,715.45 |
| Travel and Lodging | $292.33 |
| Entertainment | $13.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $5,766.09 | 2023-2025 | Myfembree |
| Abbvie INC. | $1,099.06 | 2019-2025 | Lo Loestrin Fe, Orilissa, Qulipta |
| Scynexis, INC. | $1,075.30 | 2022 | |
| Medtronic, INC. | $550.00 | 2021 | |
| Evofem Biosciences, INC. | $385.05 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $261.11 | 2021-2025 | |
| Exeltis, USA INC. | $214.45 | 2019-2025 | Slynd, Tyblume |
| Lupin INC. | $209.91 | 2019-2021 | |
| Myovant Sciences INC. | $207.87 | 2021-2022 | |
| Baxter Healthcare | $192.27 | 2021-2024 | Perclot |
| Avion Pharmaceuticals | $169.47 | 2019-2023 | Balcoltra |
| Shield Therapeutics INC | $157.05 | 2022-2025 | Accrufer |
| Novo Nordisk INC | $121.49 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Hologic Sales and Service, LLC | $117.18 | 2019-2024 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $103.03 | 2019-2024 | Ova1 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $101.81 | 2021-2022 | |
| Therapeuticsmd, INC. | $78.72 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $77.67 | 2019-2023 | Gardasil 9 |
| Dexcom, INC. | $74.00 | 2024-2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $72.79 | 2019-2020 | |
| Pfizer INC. | $60.02 | 2024 | |
| Organon LLC | $58.74 | 2021-2025 | Jada System |
| Dilon Technologies, INC. | $43.04 | 2024-2025 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $40.01 | 2019-2021 | |
| Coopersurgical, INC. | $39.63 | 2019-2023 | Endosee, Advincula Delineator Uterine Manipulator |
| Lilly USA, LLC | $31.93 | 2020-2024 | Zepbound, Jardiance |
| Millicent US INC | $31.54 | 2020 | |
| Genentech USA, INC. | $28.46 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $27.57 | 2019 | |
| Medicem INC. | $26.94 | 2020-2021 | |
| Mycovia Pharmaceuticals, INC. | $23.71 | 2023 | Vivjoa |
| Olympus America INC. | $22.22 | 2019 | |
| Daiichi Sankyo INC. | $21.56 | 2021 | |
| Alafair Biosciences, INC. | $21.03 | 2025 | Versawrap |
| Avanos Medical | $18.37 | 2021 | |
| Convatec INC. | $17.66 | 2022 | |
| Gynesonics, INC. | $17.59 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Vertical Pharmaceuticals, LLC | $17.34 | 2019 | |
| Sientra, INC. | $17.17 | 2022 | |
| Meditrina | $16.98 | 2022 | |
| Ethicon US, LLC | $15.67 | 2019 | |
| Optumhealth Care Solutions, LLC | $15.18 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Kesin Pharma Corporation | $15.00 | 2023 | Likmez |
| Sanara Medtech INC. | $14.96 | 2020 | |
| Argentum Medical | $13.54 | 2025 | |
| Innovation Technologies INC | $13.13 | 2024 | Irrisept |
| Renovia INC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.